Marshall Wace, LLP Clear Point Neuro, Inc. Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 276,632 shares of CLPT stock, worth $4.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
276,632
Previous 58,260
374.82%
Holding current value
$4.05 Million
Previous $314,000
887.58%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CLPT
# of Institutions
83Shares Held
6.81MCall Options Held
84.3KPut Options Held
56.7K-
Vanguard Group Inc Valley Forge, PA1.24MShares$18.2 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA464KShares$6.79 Million0.97% of portfolio
-
Taylor Frigon Capital Management LLC375KShares$5.48 Million2.12% of portfolio
-
Black Rock Inc. New York, NY366KShares$5.36 Million0.0% of portfolio
-
Brown Advisory Inc333KShares$4.88 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $358M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...